Enovis CORP (ENOV)

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Address

2711 CENTERVILLE ROAD
WILMINGTON, DE 19808

Founded

1995

Number of Employees

6,550

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )
- $27,367 $20,812 - $200,002 - - - - - - $82,727
Average Price - $27.75 $20.81 - $31.01 - - - - - - $29.42
# Shares Purchased - 986,279 1,000,000 - 6,449,425 - - - - - - 2,811,901
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - 55.0% 106.6% - 38.7% - - - - - - 46.2%
S&P 500 Return to Date - 173.0% 168.6% - 104.9% - - - - - - 148.8%
Excess Total Return - -118.0% -62.0% - -66.2% - - - - - - -102.6%
Quartile Rank
Percentile Rank - 49% 61% - 54% - - - - - - 69%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)